NaviGate Cardiac Structures, Inc., (NCSI)
NaviGate Cardiac Structures, Inc., (NCSI) is an early-stage company focused on developing transcatheter solutions for the treatment of atrioventricular valve regurgitation. The NaviGate valve-based technology was licensed from Cleveland Clinic and further modified and developed by NCSI. Given the unmet clinical need for patients with moderate or greater functional valve regurgitation (FTR)/ tricuspid insufficiency, NCSI is developing a catheter-guided atrioventricular valved stent for replacement of a failing tricuspid valve. Innovative anchoring mechanisms serve to secure and maintain positioning of the replacement valve.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Nationally (across the country)
Our Mission
The mission of NaviGate Cardiac Structures, Inc., is to be the leader in development of innovative transcatheter bioprosthetic heart valve implants for treating the unmet needs of atrioventricular valve disease.
The NCSI Team
The leadership team at NCSI includes a core group of professionals with considerable experience and expertise in the development of surgical and transcatheter replacement heart valves.